Get access

Perinatal Care of Women Maintained on Methadone

Authors

  • Meredith Goff CNM, and,

    Corresponding author
      Meredith Goff, CNM, Yale University School of Nursing, 100 Church St. South, New Haven, CT 06536. E-mail: meredith.goff@yale.edu
    Search for more papers by this author
  • Meghan O'Connor CNM


  • Meredith Goff, CNM, is a member of the faculty of the midwifery education program at Yale University School of Nursing.

  • Meghan O'Connor, CNM, is a member of the clinical faculty of the midwifery education program at Yale University School of Nursing.

Meredith Goff, CNM, Yale University School of Nursing, 100 Church St. South, New Haven, CT 06536. E-mail: meredith.goff@yale.edu

Abstract

A 2005 national survey found that nearly 4% of pregnant women between the ages of 15 and 44 reported illicit drug use in the previous month. Among pregnant women admitted to substance abuse programs, 15% identified heroin as the primary substance used. Methadone is a recommended treatment for pregnant women wishing to discontinue their use of heroin. Providers of peripartum care may be unaware of the specific needs of this population, which are illustrated in this case discussion.

Get access to the full text of this article

Ancillary